Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
$0.00
$0.00
$0.00
N/AN/AN/A580,821 shs
ATT
Abattis Bioceuticals
C$0.00
C$0.05
C$0.74
N/AN/A1.42 million shsN/A
Blueberries Medical Corp stock logo
BBM
Blueberries Medical
$0.00
$0.00
$0.00
N/AN/AN/A270,624 shs
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$278.04
-2.5%
$327.31
$261.59
$473.50
$7.93B0.87203,730 shs209,104 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
0.00%0.00%0.00%0.00%0.00%
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
Blueberries Medical Corp stock logo
BBM
Blueberries Medical
0.00%0.00%0.00%0.00%0.00%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
+2.04%-2.47%-18.50%-9.77%-38.15%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/AN/AN/AN/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Blueberries Medical Corp stock logo
BBM
Blueberries Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.692 of 5 stars
3.44.00.04.21.83.31.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/A
Blueberries Medical Corp stock logo
BBM
Blueberries Medical
N/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.80
Moderate Buy$468.0068.32% Upside

Current Analyst Ratings

Latest BIO, ATT, AGRA, and BBM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/3/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$400.00 ➝ $365.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$395.00 ➝ $420.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$484.00 ➝ $480.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/AN/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
Blueberries Medical Corp stock logo
BBM
Blueberries Medical
N/AN/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.67B2.97$12.02 per share23.14$306.51 per share0.91

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/AN/A0.00N/AN/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Blueberries Medical Corp stock logo
BBM
Blueberries Medical
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$637.32M-$21.49N/A24.26N/A-23.86%3.90%2.77%5/7/2024 (Confirmed)

Latest BIO, ATT, AGRA, and BBM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.04N/A-$2.04N/AN/AN/A  
2/15/2024Q4 2023
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.93$3.10+$0.17-$5.94$685.00 million$681.18 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/A
Blueberries Medical Corp stock logo
BBM
Blueberries Medical
N/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/A
Blueberries Medical Corp stock logo
BBM
Blueberries Medical
N/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.14
5.83
4.34

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Agraflora Organics International Inc stock logo
AGRA
Agraflora Organics International
N/AN/AN/ANot Optionable
ATT
Abattis Bioceuticals
N/AN/AN/ANot Optionable
Blueberries Medical Corp stock logo
BBM
Blueberries Medical
8N/AN/ANot Optionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
8,03028.52 million23.53 millionOptionable

BIO, ATT, AGRA, and BBM Headlines

SourceHeadline
S&P 500 (SPX) today: Top movers are Bio-Rad Laboratories Inc and Agilent Technologies, Inc.S&P 500 (SPX) today: Top movers are Bio-Rad Laboratories Inc and Agilent Technologies, Inc.
usatoday.com - April 23 at 3:09 PM
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Duality Advisers LPBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Duality Advisers LP
marketbeat.com - April 22 at 11:54 AM
Kornitzer Capital Management Inc. KS Cuts Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Kornitzer Capital Management Inc. KS Cuts Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)
marketbeat.com - April 20 at 11:18 AM
Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down to $290.86Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down to $290.86
americanbankingnews.com - April 20 at 6:26 AM
Commit To Purchase Bio-Rad Laboratories At $185, Earn 1.3% Annualized Using OptionsCommit To Purchase Bio-Rad Laboratories At $185, Earn 1.3% Annualized Using Options
nasdaq.com - April 19 at 11:28 PM
New Strong Sell Stocks for April 19thNew Strong Sell Stocks for April 19th
zacks.com - April 19 at 5:26 AM
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
zacks.com - April 18 at 11:06 AM
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
businesswire.com - April 18 at 9:00 AM
Bio-Rad Laboratories, Inc. (NYSE:BIO) Forecasted to Post Q1 2025 Earnings of $2.39 Per ShareBio-Rad Laboratories, Inc. (NYSE:BIO) Forecasted to Post Q1 2025 Earnings of $2.39 Per Share
americanbankingnews.com - April 18 at 2:56 AM
Bio-Rad Laboratories, Inc. (NYSE:BIO) to Post Q1 2025 Earnings of $2.39 Per Share, Zacks Research ForecastsBio-Rad Laboratories, Inc. (NYSE:BIO) to Post Q1 2025 Earnings of $2.39 Per Share, Zacks Research Forecasts
marketbeat.com - April 17 at 5:55 PM
Zacks Research Weighs in on Bio-Rad Laboratories, Inc.s Q1 2024 Earnings (NYSE:BIO)Zacks Research Weighs in on Bio-Rad Laboratories, Inc.'s Q1 2024 Earnings (NYSE:BIO)
americanbankingnews.com - April 17 at 1:22 AM
Bio-Rad (BIO) Hurt by Softness in BioPharma and CompetitionBio-Rad (BIO) Hurt by Softness in BioPharma and Competition
zacks.com - April 16 at 12:01 PM
Zacks Research Equities Analysts Reduce Earnings Estimates for Bio-Rad Laboratories, Inc. (NYSE:BIO)Zacks Research Equities Analysts Reduce Earnings Estimates for Bio-Rad Laboratories, Inc. (NYSE:BIO)
marketbeat.com - April 16 at 7:27 AM
Lecap Asset Management Ltd. Purchases New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Lecap Asset Management Ltd. Purchases New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
marketbeat.com - April 13 at 8:08 PM
Cell Lysis Cell Fractionation Market Size, Share, Growth Statistics, Latest Trends, and Forecast to 2024 to 2032Cell Lysis Cell Fractionation Market Size, Share, Growth Statistics, Latest Trends, and Forecast to 2024 to 2032
taiwannews.com.tw - April 13 at 8:01 AM
Unlock the Potential of Hydroxyapatite: 7.8% CAGR Market Opportunity in Medical ImplantsUnlock the Potential of Hydroxyapatite: 7.8% CAGR Market Opportunity in Medical Implants
fmiblog.com - April 13 at 8:01 AM
Raymond James & Associates Sells 21,649 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Raymond James & Associates Sells 21,649 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
marketbeat.com - April 12 at 4:18 AM
Bio-Rad and Alleghany Health Network partner for patients with solid tumour cancerBio-Rad and Alleghany Health Network partner for patients with solid tumour cancer
pharmatimes.com - April 11 at 11:29 PM
Bio-Rad and Allegheny Health Network Cancer Institute Collaborate to Advance Personalized Monitoring of Solid Tumor Cancers with Droplet Digital PCRBio-Rad and Allegheny Health Network Cancer Institute Collaborate to Advance Personalized Monitoring of Solid Tumor Cancers with Droplet Digital PCR
the-scientist.com - April 11 at 11:29 PM
Oncocyte, Bio-Rad Partner on Global Launch of Transplant AssayOncocyte, Bio-Rad Partner on Global Launch of Transplant Assay
marketwatch.com - April 11 at 6:28 PM
Oncocyte stock rallies 90% post-market on Bio-Rad partnershipOncocyte stock rallies 90% post-market on Bio-Rad partnership
seekingalpha.com - April 11 at 6:28 PM
Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayOncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
prismmediawire.com - April 11 at 5:44 PM
Bio-Rad Laboratories (NYSE:BIO) Stock Price Down 3.9%Bio-Rad Laboratories (NYSE:BIO) Stock Price Down 3.9%
marketbeat.com - April 11 at 1:48 PM
Allspring Global Investments Holdings LLC Has $53.64 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Allspring Global Investments Holdings LLC Has $53.64 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)
marketbeat.com - April 11 at 6:58 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Agraflora Organics International logo

Agraflora Organics International

CNSX:AGRA
AgraFlora Organics International Inc. operates in the cannabis industry in Canada and the Republic of Colombia. The company was formerly known as PUF Ventures Inc. and changed its name to AgraFlora Organics International Inc. in November 2018. The company was incorporated in 2004 and is headquartered in Vancouver, Canada.

Abattis Bioceuticals

CNSX:ATT
Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.
Blueberries Medical logo

Blueberries Medical

CNSX:BBM
Blueberries Cannabis Corp, through its subsidiaries, produces cannabis. The company is headquartered in Ontario, Canada.
Bio-Rad Laboratories logo

Bio-Rad Laboratories

NYSE:BIO
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.